Skip to main content

Jeff Lagasse

By Jeff Lagasse | 04:40 pm | January 31, 2022
The percentage of total physician compensation based on quality and cost was modest - 9% for primary care providers and 5% for specialists.
By Jeff Lagasse | 12:54 pm | January 31, 2022
Lawmakers want CMS to maintain the stability of the program, pointing to growing enrollment numbers during the pandemic.
By Jeff Lagasse | 04:30 pm | January 28, 2022
CMS credited the American Rescue Plan with lowering average monthly premiums for HealthCare.gov consumers by 23%.
By Jeff Lagasse | 12:09 pm | January 28, 2022
Some of the policies in the Notice of Benefit and Payment Parameters may limit innovation and competition, AHIP said.
By Jeff Lagasse | 04:35 pm | January 27, 2022
The investments will be aided by a strong financial showing in 2021, with total operating revenue hitting $12.4 billion.
By Jeff Lagasse | 12:41 pm | January 27, 2022
Bamlanivimab and etesevimab, which are administered in tandem, and REGEN-COV are not effective against Omicron, the FDA said.
By Jeff Lagasse | 04:11 pm | January 26, 2022
AGS believes it's premature for CMS to issue a coverage determination for other antibodies in the pipeline that don't yet have FDA approval.
By Jeff Lagasse | 11:07 am | January 26, 2022
The agency is not, however, withdrawing the emergency temporary standard as a proposed rule, saying it will work on a permanent standard.
By Jeff Lagasse | 04:12 pm | January 25, 2022
The senators framed the widespread availability of free tests - along with vaccination - as a means of eventually ending the pandemic.
By Jeff Lagasse | 12:38 pm | January 25, 2022
Uncertainty over when the waiver will end may create barriers to entry for new participants, the groups say.